Effect of the methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's disease
β Scribed by M. Robert Cooper; Thomas F. Pajak; Nis I. Nissen; Kurt Brunner; Leon Stutzman; Arthur Bank; Geoffrey Falkson; Barbara E. Barker; Farid I. Haurani; Frederick Richards II; Arlan Gottlieb; James F. Holland
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 450 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Effects of the addition of MER, a nonspecific, nonviable immunostimulant, to two combination chemotherapy programs were explored in patients with metastatic breast cancer. Patients were randomized to either CDVFP [cyclophosphamide (C), doxorubicin (D), vincristine (V), fluorouracil (F) and prednison
One-hundred-three patients with extensive non-small-cell lung cancer were entered into a prospective, randomized trial to determine the value of MER as an adjuvant to chemotherapy. Patients were stratified according to histology and performance status. All patients received CCNU, methotrexate, and A
Twenty-one patients with malignant melanoma stage III and IV were treated by intradermal injections of MER--methanol extraction residue of Baccillus Calmette-GuΓ©rin (BCG). Twelve of the patients, all with active disease, received chemotherapy in addition. Tests of skin reactivity to recall antigens